The Joel Evan Show
In this conversation, Joel Evan interviews Mac Davis, the founder and CEO of Mini Circle, a pioneering company in gene therapy. They discuss Mac's unique background as a former monk and how it influenced his journey into biotechnology. The conversation delves into the mechanisms of gene therapy, particularly focusing on full-statin, its potential to reverse aging, and the safety of such treatments. Mac shares insights from clinical trials, real-world applications, and the process of receiving gene therapy. They also explore the future of gene therapy, including upcoming projects and the broader implications for health and longevity. Takeaways Mac Davis is the founder and CEO of Mini Circle, a gene therapy company. Gene therapy uses genes to influence health and well-being. Follostatin is a gene therapy known for its anti-aging effects. Clinical trials showed significant increases in telomere length. The therapy is administered via a non-invasive injection. The cost of the therapy is currently set at $25,000. There are no reported negative side effects from full-statin therapy. Future projects include Clotho gene therapy, which has potential cognitive benefits. Gene therapy could become a widely available option for longevity. Exercise can naturally increase levels of full-statin in the body. Chapters 00:00 Introduction to Gene Therapy and Mac's Journey 02:55 Understanding Gene Therapy: Mechanisms and Safety 05:57 The Science Behind Full-Statin and Aging 08:58 Real-World Applications and Experiences with Full-Statin 12:02 The Process of Receiving Gene Therapy 14:43 Future of Gene Therapy and Upcoming Innovations
